Development of luciferase tagged brain tumour models in mice for chemotherapy intervention studies

E. Marleen Kemper(Amsterdam University Medical Centers), Olaf van Tellingen(Dutch Cancer Society), Scott K. Lyons(Cold Spring Harbor Laboratory), Jos H. Beijnen(The Netherlands Cancer Institute), Arend Heerschap(Radboud University Nijmegen), Tessa Buckle(Leiden University Medical Center), Benno Küsters(Radboud University Nijmegen), Willem Boogerd(The Netherlands Cancer Institute), William P. J. Leenders(Radboud University Nijmegen)
European Journal of Cancer
October 6, 2006
10.1016/j.ejca.2006.07.013
Cited by 51

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
|Science|2018|1.5k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884